Richard has over 25 years industry experience in the environmental risk assessment (ERA) of general chemicals and human medicines.  Previously Head of AstraZeneca Global Environmental Risk Assessment he is fully conversant with the technical ERA requirements under EU REACH, EMA and US FDA.  He has represented AZ and national and EU pharmaceutical trade associations on ERA issues and been an active member/participant in several ECETOC and OECD taskforces, SETAC Pellston and DIA workshops and seminars on ’pharmaceuticals in the environment’ and ERA of pharmaceuticals.

Richard also supports the operational management of RSA, coordinating responses to new enquiries, pulling together project teams and ensuring that projects are appropriately resourced.  He has an analytical, ‘fit for purpose’ mind-set and is highly customer-focused, with a track record of delivering quality outputs to meet client and regulatory needs.